Palumbo Wealth Management’s Cidara Therapeutics CDTX Stock Holding History

Palumbo Wealth Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,283	Closed	-$725K	–	223
2025 Q4	$725K	Buy	3,283 +494	+18%	+$79.8K	0.18%	93
2025 Q3	$267K	Buy	+2,789	New	+$178K	0.09%	146

Palumbo Wealth Management's CDTX Position: Q1 2026 in Review

Palumbo Wealth Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 3,283 shares — an estimated $725K sold.

Palumbo Wealth Management first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $725K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Palumbo Wealth Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Palumbo Wealth Management sold 3,283 Cidara Therapeutics shares in Q1 2026, an estimated $725K.
Palumbo Wealth Management first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Palumbo Wealth Management's Cidara Therapeutics position peaked at $725K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.